Release testing involves both standard potency assays and unique assays (particle size, NA activity) developed to ensure the physical, chemical, and biological stability of this type of vaccine.
Steven Pincus
Advertisement
Steven Pincus is the head of analytical and quality operations at Novavax Inc.
Articles by Steven Pincus
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
3
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
4
Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals
5